
People use Neurotoxins primarily to smooth and prevent dynamic wrinkles primarily those around the eyes, mouth and forehead. Injecting a neurotoxin relaxes those specific underlying muscles, softening existing lines and preventing new ones from deepening.

First approved by the FDA in 2002 for cosmetic use. Botox remains the most recognized brand globally. This is best for precision treatment because it tends to stay localized to where it was injected. It is favored for small or precise areas such as crows feet or delicate brow lines.

Dysport uses smaller molecular weight structure that allows it to diffuse slightly farther from the injection point. Best for larger surfaces such as broad foreheads. It offers a blending effect and has the fastest onset time (often showing results in 48 to 72 hours).

Marketed explicitly for aesthetics rather than medical conditions, Jeuveau was engineered to match Botox's performance. This product is best for value - focused precision. It acts similarly to Botox but often carries a lower price due to manufacturer rewards and pricing structures.

Xeomin undergoes a specialized purification process that removes accessory proteins, leaving only the active therapeutic molecule. This product is best for patients who are seeking a minimalist formula or those who have developed antibody resistance to other Neurotoxins.

Letybo has been long been the dominant market leader in South Korea and Asia. It gained FDA approval in 2024. It's best for high consistency and purity. It provides 3-4 month longevity and offers competitive pricing due to expansion in the US.
Thrive Health
Located at 12502 Promise Creek Lane, Suite 426, Fishers, IN and Located at 621 North State Street, Greenfield, IN. Text or call number below with questions or to book appt.
Copyright © 2026 Elevate Health Medical PC DBA Thrive Health - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.